Initial Therapeutics logo
VerifiedBiotechnology Research· Founded 2020

Initial Therapeutics

Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages. Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.

7-day free trial · no credit card

HeadquartersSouth San Francisco, United StatesEmployees17(11 to 50)Founded year2020Websiteinitialtx.comLinkedIn profileLinkedIn

Verified contacts

19

available on Kipplo

LinkedIn employees

17

11 to 50 range

Open roles

1

across 1 depts

Distinct roles

12

indexed titles

Tech stack

2

tools in use

Monthly traffic

383

organic / mo

Hiring · 1 open positions across 1 departments

Marketing1

Sign up free to see all 19 verified contacts at Initial Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

19 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Initial Therapeutics

12 distinct titles indexed · top 10 shown.

  • 3research associate
  • 1associate scientist
  • 1compound management
  • 1consultant
  • 1director, tumor biology & biomarker research
  • 1executive assistant
  • 1scientist
  • 1scientist 1
  • 1scientist i - computational biology
  • 1scientist ii
  • +2more titles

Sign up to unlock all 19 contacts at Initial Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 19 verified contacts at Initial Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Initial Therapeutics | Kipplo Discover